跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retalac - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retalac
Approved
STANDARD
Retalac
Panacea Biotec Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8f25116f42fd38fc
Company
Panacea Biotec Pharma Limited
Type
Standard
Approval Details
Approval Id
8f25116f42fd38fc
Drug Approval Philippines Name
Retalac
Product Name
Retalac
Registration Number
DRP-12458-02
Brand Name
Retalac
Generic Name
Lactulose
Dosage Form
Oral Solution
Dosage Strength
3.35 g/5mL
Manufacturer
Panacea Biotec Pharma Limited
Importer
Medinova Pharmaceutical Inc
Distributor
Reta Drug
Company Detail Path
/organization/panacea-biotec-pharma-limited
Issuance Date
02 November 2023
Expiry Date
12 August 2027
Pharmacologic Category
Osmotically Acting Laxative
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8f25116f42fd38fc
Type
Standard
Back to Philippines FDA Approvals